Tag Archive
Nanostart-Owned MagForce Nanotechnologies AG: Application Submitted For EU Regulatory Approval Of Nano-Cancer(R) Therapy (Medical News Today)
MagForce Nanotechnologies AG, the Berlin-based medical nanotechnology company majority owned by Nanostart AG, has submitted its application for the European regulatory approval of its Nano-Cancer® therapy. The application is based on the successful results of recent clinical trials involving patients with recurrent glioblastoma, an especially aggressive form of brain tumor… (read the story…) Related items MagForce Nanotechnologies... »
MagForce Nanotechnologies completes clinical trial of Nano-Cancer therapy in glioblastoma patients (News-Medical-Net)
MagForce Nanotechnologies AG has successfully completed its single-arm clinical trial on the efficacy of thermotherapy using superparamagnetic nanoparticles in patients with recurrent glioblastoma. (read the story…) Related items MagForce Nanotechnologies AG reaches primary study endpoint in pivotal glioblastoma study (Business Wire via Yahoo! Finance) Nanostart-Owned MagForce Nanotechnologies AG: Application Submitted For EU Regulatory Approval Of Nano-Cancer(R) Therapy (Medical... »
MagForce Nanotechnologies AG reaches primary study endpoint in pivotal glioblastoma study (Business Wire via Yahoo! Finance)
BERLIN—-MagForce Nanotechnologies AG has successfully completed its single-arm clinical trial on the efficacy of thermotherapy using superparamagnetic nanoparticles in patients with recurrent glioblastoma. (read the story…) Related items MagForce Nanotechnologies completes clinical trial of Nano-Cancer therapy in glioblastoma patients (News-Medical-Net) MagForce Nanotechnologies Completes Patient Recruitment for Pivotal Glioblastoma Study (Business Wire via Yahoo! Finance) Gold nanoparticles for cancer treatment... »
MagForce Nanotechnologies Completes Patient Recruitment For Pivotal Glioblastoma Study (Medical News Today)
MagForce Nanotechnologies AG (FWB:MF6) has successfully completed patient recruitment for its study on recurrent glioblastoma, which is of critical importance for demonstrating the efficacy of its proprietary Nano-Cancer® therapy. (read the story…) Related items MagForce Nanotechnologies Completes Patient Recruitment for Pivotal Glioblastoma Study (Business Wire via Yahoo! Finance) Nanostart-Owned MagForce Nanotechnologies AG: Application Submitted For EU Regulatory Approval... »
MagForce Nanotechnologies Completes Patient Recruitment for Pivotal Glioblastoma Study (Business Wire via Yahoo! Finance)
BERLIN—-MagForce Nanotechnologies AG has successfully completed patient recruitment for its study on recurrent glioblastoma, which is of critical importance for demonstrating the efficacy of its proprietary Nano-Cancer® therapy. (read the story…) Related items MagForce Nanotechnologies Completes Patient Recruitment For Pivotal Glioblastoma Study (Medical News Today) Nanostart-Owned MagForce Nanotechnologies AG: Application Submitted For EU Regulatory Approval Of Nano-Cancer(R) Therapy... »
